Literature DB >> 35275324

Left atrial appendage closure in patients with intracranial hemorrhage: the clock is ticking - to take the bull by the horn or wait for a randomized controlled trial : Editorial commentary regarding "Left atrial appendage closure in patients with intracranial hemorrhage" by Garg and colleagues.

Alberto Alfie1, Patrick Müller2.   

Abstract

Entities:  

Year:  2022        PMID： 35275324     DOI： 10.1007/s10840-022-01180-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  10 in total

1.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Authors:  Vivek Y Reddy; Horst Sievert; Jonathan Halperin; Shephal K Doshi; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Brian Whisenant; Saibal Kar; Vijay Swarup; Nicole Gordon; David Holmes
Journal:  JAMA       Date:  2014-11-19       Impact factor: 56.272

2.  Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.

Authors:  Lucas V Boersma; Hueseyin Ince; Stephan Kische; Evgeny Pokushalov; Thomas Schmitz; Boris Schmidt; Tommaso Gori; Felix Meincke; Alexey Vladimir Protopopov; Timothy Betts; Patrizio Mazzone; David Foley; Marek Grygier; Horst Sievert; Tom De Potter; Elisa Vireca; Kenneth Stein; Martin W Bergmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-04

3.  Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.

Authors:  Pavel Osmancik; Dalibor Herman; Petr Neuzil; Pavel Hala; Milos Taborsky; Petr Kala; Martin Poloczek; Josef Stasek; Ludek Haman; Marian Branny; Jan Chovancik; Pavel Cervinka; Jiri Holy; Tomas Kovarnik; David Zemanek; Stepan Havranek; Vlastimil Vancura; Jan Opatrny; Petr Peichl; Petr Tousek; Veronika Lekesova; Jiri Jarkovsky; Martina Novackova; Klara Benesova; Petr Widimsky; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2020-06-30       Impact factor: 24.094

4.  Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial.

Authors:  Saibal Kar; Shephal K Doshi; Ashish Sadhu; Rodney Horton; Jose Osorio; Christopher Ellis; James Stone; Manish Shah; Srinivas R Dukkipati; Stuart Adler; Devi G Nair; Jamie Kim; Oussama Wazni; Mathew J Price; Federico M Asch; David R Holmes; Robert D Shipley; Nicole T Gordon; Dominic J Allocco; Vivek Y Reddy
Journal:  Circulation       Date:  2021-04-06       Impact factor: 29.690

5.  4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.

Authors:  Pavel Osmancik; Dalibor Herman; Petr Neuzil; Pavel Hala; Milos Taborsky; Petr Kala; Martin Poloczek; Josef Stasek; Ludek Haman; Marian Branny; Jan Chovancik; Pavel Cervinka; Jiri Holy; Tomas Kovarnik; David Zemanek; Stepan Havranek; Vlastimil Vancura; Petr Peichl; Petr Tousek; Veronika Lekesova; Jiri Jarkovsky; Martina Novackova; Klara Benesova; Petr Widimsky; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2021-11-05       Impact factor: 27.203

6.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Authors:  Vivek Y Reddy; Sven Möbius-Winkler; Marc A Miller; Petr Neuzil; Gerhard Schuler; Jens Wiebe; Peter Sick; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

7.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.

Authors:  Vivek Y Reddy; Shephal K Doshi; Saibal Kar; Douglas N Gibson; Matthew J Price; Kenneth Huber; Rodney P Horton; Maurice Buchbinder; Petr Neuzil; Nicole T Gordon; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2017-11-04       Impact factor: 24.094

8.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

9.  Left atrial appendage closure in patients with intracranial hemorrhage.

Authors:  Jalaj Garg; Siddharth Shah; Kuldeep Shah; Rahul Bhardwaj; Tahmeed Contractor; Ravi Mandapati; Mohit K Turagam; Andrea Natale; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2022-02-02       Impact factor: 1.759

10.  Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.

Authors:  Sigrun Halvorsen; Dan Atar; Hongqiu Yang; Raffaele De Caterina; Cetin Erol; David Garcia; Christopher B Granger; Michael Hanna; Claes Held; Steen Husted; Elaine M Hylek; Petr Jansky; Renato D Lopes; Witold Ruzyllo; Laine Thomas; Lars Wallentin
Journal:  Eur Heart J       Date:  2014-02-20       Impact factor: 29.983
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.